Marex Group »

BioMarin Pharmaceutical shares owned by Marex Group

Quarter-by-quarter ownership of BioMarin Pharmaceutical (BMRN) shares owned by Marex Group from 13F filings

Historical chart of Marex Group investment in BioMarin Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including BioMarin Pharmaceutical held by Marex Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioMarin Pharmaceutical by Marex Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.4M 27k 54.16
2025-06-30 $755k 14k 54.97

More positions owned by Marex Group

Tesla Motors Call Option (TSLA)
Mastercard Incorporated Cl A (MA)
Booking Holdings (BKNG)
Microsoft Corporation Call Option (MSFT)
Strategy Cl A New (MSTR)
UnitedHealth (UNH)
NVIDIA Corporation Call Option (NVDA)
Eli Lilly & Co. (LLY)
Valkyrie Bitcoin (BRRR)
Apple (AAPL)
Netflix (NFLX)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Meta Platforms Cl A (META)
Broadcom Call Option (AVGO)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)

View all positions for Marex Group

Top funds holding BioMarin Pharmaceutical

BlackRock
Vanguard Group
PRIMECAP Management Company
Dodge & Cox
State Street Corporation
Viking Global Investors
AQR Capital Management
Geode Capital Management
Millennium Management
Capital Research Global Investors
UBS Group
Dimensional Fund Advisors
Renaissance Technologies
Northern Trust
Man Group

View all funds holding BioMarin Pharmaceutical